Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non-Small Cell Lung Cancer: A Meta-analysis.
Tauseef A, Zafar M, Silberstein P, Nahas J, Frederickson T, Hansen S, Abbas A, Alali Y, Buragadda A, Abughanimeh OK, Nair S, Thirumalareddy J, Mirza M.
Tauseef A, et al.
Fed Pract. 2022 Aug;39(Suppl 3):S72-S80. doi: 10.12788/fp.0309. Epub 2022 Aug 13.
Fed Pract. 2022.
PMID: 36426108
Free PMC article.
Review.